MoneyWorks4Me

Cadila Healthcare informs about quarterly statement on investor complaints

06 Apr 2016 Evaluate

Cadila Healthcare has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1755.20
Dr. Reddys Labs. 1233.00
Cipla 1326.10
Lupin 1965.75
Zydus Lifesciences 1113.95
View more..